CUL3-mediated NRF2 dysregulation in TP53-driven non-small cell lung cancer: neddylation-associated structural perturbations
- 1Department of Biotechnology, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India
Abstract
CUL3 encodes Cullin-3, the scaffold of Cullin-RING Ligase 3 (CRL3), which mediates proteasomal degradation of NRF2 through KEAP1-dependent ubiquitination. While canonical NRF2 alterations such as KEAP1 or NFE2L2 mutations are well characterised in non-small cell lung cancer (NSCLC), the role of CUL3 mutations remains poorly defined. We hypothesised that CUL3 missense variants are conditionally enriched in TP53-altered NSCLC, with the EGFR-oncogenic subset as a defined disease background rather than a synergistic requirement. A multi-cohort NSCLC dataset (n = 47,862; 10,228 with oncogenic EGFR mutations and confirmed CUL3 coverage) was interrogated using two-layer Fisher’s exact testing and logistic regression with an EGFR × TP53 interaction term, and validated transcriptomically in TCGA LUAD/LUSC. CUL3 mutations showed conditional enrichment in the TP53-mutant EGFR background (OR = 2.92, p = 4.68 × 10−29); the non-significant EGFR × TP53 interaction (OR = 0.86, p = 0.547) confirmed that enrichment is driven by TP53 loss rather than EGFR synergy. CUL3-mutant tumours showed elevated NRF2 activation across three independent signatures, with increased proliferative signalling and altered drug metabolism. All-atom molecular dynamics simulations of wild-type, L321F, G402E and M711I CUL3:KEAP1 complexes in inactive and neddylation-active states revealed variant-specific conformational behaviour. L321F drove the neddylated complex into a conformationally restricted state with reduced backbone flexibility, decreased radius of gyration, and a shifted free energy minimum, whereas G402E showed progressive destabilisation and M711I remained comparable to wild-type. Free energy landscape analysis confirmed a shifted conformational energy minimum in L321F + NEDD8 relative to wild-type, indicating impaired catalytic flexibility despite intact complex formation. These findings define CUL3 as a TP53-associated modifier of NRF2 regulation within EGFR-driven NSCLC, operating through allosteric rigidification of the neddylation-active CRL3 complex.
Related
- Dengue virus-induced thrombocytopenia is mediated by dysregulation of the RUNX1-MYH9 axis
- Water as an Active Medium: Distinct Structural-Dynamic Regimes Revealed by Trace Perturbations
- Gut microbiota–mediated tryptophan metabolic dysregulation in the comorbidity of inflammatory bowel disease and autism spectrum disorder: mechanisms and research progress
- Long non-coding RNAs in monocyte/macrophage-mediated immune dysregulation and organ injury in sepsis: mechanistic insights and therapeutic potential.
- Mutation-induced structural and dynamic perturbations at the IL-17A–IL-17RA interface: Therapeutic insights from multi-replicate molecular dynamics simulations
BibTeX
@article{dharmalingam2026cul3mediated,
title = {{CUL3-mediated NRF2 dysregulation in TP53-driven non-small cell lung cancer: neddylation-associated structural perturbations}},
author = {Poobana Dharmalingam and C. Sudandiradoss},
journal = {Frontiers in Bioinformatics},
year = {2026},
month = oct,
doi = {10.3389/fbinf.2026.1918128},
url = {https://doi.org/10.3389/fbinf.2026.1918128},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - CUL3-mediated NRF2 dysregulation in TP53-driven non-small cell lung cancer: neddylation-associated structural perturbations
AU - Poobana Dharmalingam
AU - C. Sudandiradoss
PY - 2026
DA - 2026/10/30
JO - Frontiers in Bioinformatics
DO - 10.3389/fbinf.2026.1918128
UR - https://doi.org/10.3389/fbinf.2026.1918128
AB - CUL3 encodes Cullin-3, the scaffold of Cullin-RING Ligase 3 (CRL3), which mediates proteasomal degradation of NRF2 through KEAP1-dependent ubiquitination. While canonical NRF2 alterations such as KEAP1 or NFE2L2 mutations are well characterised in non-small cell lung cancer (NSCLC), the role of CUL3 mutations remains poorly defined. We hypothesised that CUL3 missense variants are conditionally enriched in TP53-altered NSCLC, with the EGFR-oncogenic subset as a defined disease background rather than a synergistic requirement. A multi-cohort NSCLC dataset (n = 47,862; 10,228 with oncogenic EGFR mutations and confirmed CUL3 coverage) was interrogated using two-layer Fisher’s exact testing and logistic regression with an EGFR × TP53 interaction term, and validated transcriptomically in TCGA LUAD/LUSC. CUL3 mutations showed conditional enrichment in the TP53-mutant EGFR background (OR = 2.92, p = 4.68 × 10−29); the non-significant EGFR × TP53 interaction (OR = 0.86, p = 0.547) confirmed that enrichment is driven by TP53 loss rather than EGFR synergy. CUL3-mutant tumours showed elevated NRF2 activation across three independent signatures, with increased proliferative signalling and altered drug metabolism. All-atom molecular dynamics simulations of wild-type, L321F, G402E and M711I CUL3:KEAP1 complexes in inactive and neddylation-active states revealed variant-specific conformational behaviour. L321F drove the neddylated complex into a conformationally restricted state with reduced backbone flexibility, decreased radius of gyration, and a shifted free energy minimum, whereas G402E showed progressive destabilisation and M711I remained comparable to wild-type. Free energy landscape analysis confirmed a shifted conformational energy minimum in L321F + NEDD8 relative to wild-type, indicating impaired catalytic flexibility despite intact complex formation. These findings define CUL3 as a TP53-associated modifier of NRF2 regulation within EGFR-driven NSCLC, operating through allosteric rigidification of the neddylation-active CRL3 complex.
SN - 2673-7647
ER -